UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------------
FORM 8-K\A
Amendment No.1 to
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported) February
17, 1995
Chemfab Corporation
(Exact Name of registrant as specified in charter)
Delaware 0-12948 03-0221503
(State or other (Commission (IRS employer
jurisdiction of file number) identification
incorporation no.)
701 Daniel Webster Highway, Merrimack, New Hampshire 03054
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (603) 424-9000
(Former name or former address, if changed since last report)
Item 7 Financial Statements, and Exhibits
- ------ ----------------------------------
7(a) The audited financial statements of Fothergill Tygaflor Division of
Courtaulds Aerospace Limited (Tygaflor) for its fiscal year ended
March 31, 1994 and the 10 1\2 months ended February 17, 1995 are
attached hereto as an exhibit.
7(b) The pro forma financial information required pursuant to Article 11 of
Regulation S-X is attached hereto as an exhibit.
7(c) Exhibits
1. 10(b)(8) Asset Purchase Agreement between Chemfab Corporation,
Chemfab U.K. Ltd., Courtaulds plc and Courtaulds Aerospace
Limited dated February 13, 1995.
1. 10(b)(9) Facilities Agreement between Chemfab Europe, Chemfab
Holdings U.K. Ltd., Chemfab U.K. Ltd. and Bank of Ireland
dated February 17, 1995.
1. 10(b)(10) Guarantee and Indemnity between Chemfab Corporation and the
Bank of Ireland dated February 17, 1995.
2. 10(b)(11) Balance sheets of Tygaflor as of March 31, 1994 and February
17, 1995, the related statements of income and cash flows
for the periods then ended, and the report of Ernst and
Young LLP thereon.
2. 10(b)(12) Unaudited pro forma combined balance sheet of the registrant
and Tygaflor as of January 1, 1995, unaudited pro forma
statements of income for the year ended June 30, 1994 and
the six months ended January 1, 1995 and explanatory notes
thereto.
_______________________________________________________________________
1. Attached as an exhibit to this report on Form 8-K as
originally filed on March 2, 1995.
2. Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: May 8, 1995
---------------------
CHEMFAB CORPORATION
By: /s/ William H. Everett
---------------------------
Title: Vice President
-----------------------